News
| 5 min read
A new in vivo approach programs patients’ T cells directly, bypassing complex manufacturing and expanding access to CAR T therapies.
| 6 min read
Researchers are exploring both broad multi-cancer tests and targeted approaches for hard-to-detect tumors, but clinical validation is still needed.
| 4 min read
FDA approvals, mass spectrometry advancements, personalized gene therapies, and more led the news this week.
| 5 min read
Advances in high-throughput experimentation and machine learning are helping researchers map how gut microbes influence drug response and health outcomes.
| 4 min read
Scientists have developed a new CAR-T manufacturing method using a multi-cytokine scaffold that produces longer-lived immune cells capable of self-renewal.
| 2 min read
New research suggests vascular aging markers may offer clinicians an early warning tool.
| 2 min read
Chromatin profiling across cancer cell lines maps nuclear enzyme localization, linking metabolic reprogramming to DNA repair and treatment resistance.
| 4 min read
A large long-term study in women shows a simple blood test can identify who is most at risk of developing dementia decades before memory problems appear.
| 4 min read
Unexpected breakthroughs in drug manufacturing, lawsuits, regulatory updates, and more led the news this week.
| 4 min read
A new study shows how specific gut bacteria work with diet to trigger fat browning in mice, revealing potential pathways for future metabolic therapies.
| 5 min read
Ireland’s model for advanced therapy manufacturing integrates academic research, workforce development, and regulatory bodies to streamline the production of complex biologics.
| 4 min read
A new bacterial platform can produce millions of stabilized peptides in a single experiment, accelerating the search for therapies against hard-to-drug targets.
